Factors that influence the recruitment of patients to Phase III studies in oncology

BACKGROUND The multiple determinants of a patient's decision to enter into a clinical trial have been explored largely from the perspectives of patients and their physicians. Little research has involved clinical research associates (CRAs) formally, despite their central role in the process of...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2002-10, Vol.95 (7), p.1584-1591
Main Authors: Wright, James R., Crooks, Dauna, Ellis, Peter M., Mings, Deborah, Whelan, Tim J.
Format: Article
Language:English
Subjects:
clinical research associate
clinical trial recruitment
focus group
patient participation
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND The multiple determinants of a patient's decision to enter into a clinical trial have been explored largely from the perspectives of patients and their physicians. Little research has involved clinical research associates (CRAs) formally, despite their central role in the process of recruitment. The current study was initiated to explore the factors that influence the decision of patients with cancer regarding clinical trial entry, specifically from the perspective of the CRA. METHODS Two focus groups of CRAs from the Hamilton Regional Cancer Center were organized. A skilled facilitator guided both groups through exploratory and subsequent confirmatory phases of discussions, which were audiotaped for review and coding using a process of consensus employing intercoder triangulation. RESULTS The two groups identified a number of factors that they believed influenced the recruitment process. Numerous physician and patient factors were reaffirmed, such as the impression of the scientific merit of a study or the sense of personal benefit, respectively. More uniquely, CRAs identified information transfer within the informed consent process as a major aspect of their specialized role. It was believed that full disclosure of information, in terms of both the content and the techniques and styles of delivery, was an important predictor of recruitment success. The groups quickly reached consensus on which factors they believed were the most important overall with respect to influencing study recruitment. CONCLUSIONS CRAs appear to have a unique role in the process of recruiting patients to active clinical trials. They believe that they have an important influence on recruitment success. Further research to validate this impression is required, because, ultimately, a greater understanding of the relative roles of physician and patient factors and, potentially, CRA factors will be important in the development of ethical and supportive strategies to optimize the recruitment of patients with cancer into randomized clinical trials. Cancer 2002;95:1584–91. © 2002 American Cancer Society. DOI 10.1002/cncr.10864 Clinical research associates believe they have an important, influential role in the recruitment of patients with cancer to Phase III clinical trials. A greater understanding of all patient, physician, and research associate factors is required to develop supportive strategies to optimize patient accrual. See also pages 1397–400 and 1577–83.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.10864